Results for tag: "Interleukin 13"

Interleukin 13 (IL-13) is a cytokine that plays a role in the regulation of the immune system. It is involved in the development of immune disorders such as asthma, allergies, and inflammatory bowel disease. IL-13 is a key target for drug development in the immune disorders market, as it has been shown to reduce inflammation and improve symptoms. IL-13 is a promising target for drug development due to its ability to modulate the immune system. It has been shown to reduce inflammation and improve symptoms in a variety of immune disorders. Additionally, IL-13 has been shown to be effective in combination with other drugs, making it a viable option for combination therapies. Several companies are developing drugs targeting IL-13 for the treatment of immune disorders. These include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more